(Q35807149)

10 August 2017

title

Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH. (English)

1 reference

10 August 2017

0 references

0 references

Tiny Jaarsma

4

0 references

Dirk J van Veldhuisen

series ordinal

3

object named as

Dirk J van Veldhuisen

1 reference

10 August 2017

5

Hans L Hillege

1 reference

10 August 2017

8

Adriaan A Voors

1 reference

10 August 2017

7

Salvatore Di Somma

1 reference

10 August 2017

9

W Frank Peacock

1 reference

10 August 2017

Wouter C Meijers

1

1 reference

10 August 2017

Rudolf A de Boer

series ordinal

2

1 reference

10 August 2017

Alan S Maisel

series ordinal

6

1 reference

10 August 2017

publication date

14 October 2015

1 reference

European Journal of Heart Failure

10 August 2017

published in

1 reference

10 August 2017

volume

17

1 reference

10 August 2017

issue

12

1 reference

10 August 2017

page(s)

1271-1282

1 reference

The current cost of heart failure to the National Health Service in the UK.

10 August 2017

cites work

1 reference

Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure

21 January 2018

1 reference

Rehospitalizations among patients in the Medicare fee-for-service program

21 January 2018

1 reference

The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure.

21 January 2018

1 reference

The Seattle Heart Failure Model: prediction of survival in heart failure

21 January 2018

1 reference

Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score

21 January 2018

1 reference

State of the Art: Newer biomarkers in heart failure

21 January 2018

1 reference

Biomarkers of heart failure with normal ejection fraction: a systematic review

21 January 2018

1 reference

Cardiac troponin and outcome in acute heart failure

21 January 2018

1 reference

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

21 January 2018

1 reference

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

21 January 2018

1 reference

Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).

21 January 2018

1 reference

Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure

21 January 2018

1 reference

B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction

21 January 2018

1 reference

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials

21 January 2018

1 reference

Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure

21 January 2018

1 reference

The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure

21 January 2018

1 reference

Risk prediction in patients with heart failure: a systematic review and analysis

21 January 2018

1 reference

Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure

21 January 2018

1 reference

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

21 January 2018

1 reference

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

21 January 2018

1 reference

Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study

21 January 2018

1 reference

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

21 January 2018

1 reference

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure

21 January 2018

1 reference

Galectin-3: a novel mediator of heart failure development and progression

21 January 2018

1 reference

Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis

21 January 2018

1 reference

Prognostic value of serum galectin-3 in patients with heart failure: a meta-analysis

21 January 2018

1 reference

Galectin-3 in heart failure with preserved ejection fraction

21 January 2018

1 reference

Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial.

21 January 2018

1 reference

Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin

21 January 2018

1 reference

A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score

21 January 2018

1 reference

Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF.

21 January 2018

1 reference

Natriuretic peptide-guided heart failure management

21 January 2018

1 reference

Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

21 January 2018

1 reference

Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.

21 January 2018

1 reference

Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure

21 January 2018

1 reference

Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT.

21 January 2018

1 reference

Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study

21 January 2018

1 reference

Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis.

21 January 2018

1 reference

Effect of hospital follow-up appointment on clinical event outcomes and mortality

21 January 2018

1 reference

The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure

21 January 2018

1 reference

Repeated hospitalizations predict mortality in the community population with heart failure

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJHF.407

1 reference

10 August 2017

1 reference